3 results
primaryTo assess the safety and tolerability of multiple, once-daily oral doses of RDN-929 over 28 days in healthy older adult subjects and early symptomatic AD subjects.secondaryTo assess the plasma and CSF pharmacokinetics (PK) of RDN-929 in…
The purpose of this study is to determine if the combination of relatlimab and nivolumab improves overall survival (OS) in all randomized participants and participants with PD-L1 CPS >= 1 with later-line metastatic colorectal cancer compared…
The main objective of this trial is to investigate the ability to visualize the exact location of left and right confluence of the bile ducts and thereby distinct between right and left hepatic ducts and the common hepatic duct using NIRF imaging.…